MPO TIP FR-TI1/525
« backIntellMed, Ltd. participates in the project of the Ministry of Industry and Trade called EGFR and KRAS diagnostics for targeted cancer therapy (MPO TIP FR-TI1/525). The aim of the project is research and development of original molecular diagnostics for optimization of expensive anticancer therapy directed again HER1 (EGFR1) receptor particularly in colorectal, head and neck and non-small cell lung cancer patients, including FISH diagnostics of HER1 gene, PCR diagnosis of HER1 and KRAS mutations. Complete diagnostic system is not currently available on the market and its introduction would allow further rationalization of anticancer therapy.